Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ANDA Approval Times Get Optimistic Estimate In Budget Request

May 26 2017

• By Derrick Gingery

Samples of medicines, tablets, capsules, vitamins, and placebo

Related Content

ANDA Reviews: First-Cycle Desired, But Two-Cycles OK?

Jul 27 2015

ANDA Submissions Continue Yo-Yo Pattern, Unlike Approvals

May 10 2017

GDUFA Performance Goals For Fiscal Years 2013-2017

Dec 12 2011

ANDA Time To Approval, First Action Curves Need To Bend

May 04 2015

ANDA Review Times Will Not Come Down In Next Two Years, FDA Predicts

Feb 10 2015

Generic Drug First-Cycle Approval Rates Lagging Under GDUFA I

Oct 26 2016

Additional Topics

United States FDA Generic Drugs Drug Review Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window